1-6 of 6
hepcidin
Close
Sort by
Journal Articles

Loss of erythroblasts in acute myeloid leukemia causes iron redistribution with clinical implications

Clinical Trials & Observations
Marta Lopes, Tiago L. Duarte, Maria J. Teles, Laura Mosteo, Sérgio Chacim, Eliana Aguiar, Joana Pereira-Reis, Mónica Oliveira, André M. N. Silva, Nuno Gonçalves, Gabriela Martins, Isabella Y. Kong, Magnus Zethoven, Stephin Vervoort, Sandra Martins, Miguel Quintela, Edwin D Hawkins, Fernanda Trigo, João T. Guimarães, José M. Mariz, Graça Porto, Delfim Duarte
Journal: Blood Advances
Blood Adv (2021) 5 (16): 3102–3112.
https://doi.org/10.1182/bloodadvances.2021004373
Published: 2021
Includes: Supplemental data
Journal Articles

ACVR1/JAK1/JAK2 inhibitor momelotinib reverses transfusion dependency and suppresses hepcidin in myelofibrosis phase 2 trial

Clinical Trials & Observations
Stephen T. Oh, Moshe Talpaz, Aaron T. Gerds, Vikas Gupta, Srdan Verstovsek, Ruben Mesa, Carole B. Miller, Candido E. Rivera, Angela G. Fleischman, Swati Goel, Mark L. Heaney, Casey O’Connell, Murat O. Arcasoy, Yafeng Zhang, Jun Kawashima, Tomas Ganz, Mark Kowalski, Carrie Baker Brachmann
Journal: Blood Advances
Blood Adv (2020) 4 (18): 4282–4291.
https://doi.org/10.1182/bloodadvances.2020002662
Published: 2020
Includes: Supplemental data
Journal Articles

Neutrophils from hereditary hemochromatosis patients are protected from iron excess and are primed

Cyril Renassia, Sabine Louis, Sylvain Cuvellier, Nadia Boussetta, Jean-Christophe Deschemin, Didier Borderie, Karine Bailly, Joel Poupon, Pham My-Chan Dang, Jamel El-Benna, Sandra Manceau, François Lefrère, Sophie Vaulont, Carole Peyssonnaux
Journal: Blood Advances
Blood Adv (2020) 4 (16): 3853–3863.
https://doi.org/10.1182/bloodadvances.2020002198
Published: 2020
Includes: Supplemental data
Journal Articles

Plasma hepcidin is associated with future risk of venous thromboembolism

Clinical Trials & Observations
Trygve S. Ellingsen, Jostein Lappegård, Thor Ueland, Pål Aukrust, Sigrid K. Brækkan, John-Bjarne Hansen
Journal: Blood Advances
Blood Adv (2018) 2 (11): 1191–1197.
https://doi.org/10.1182/bloodadvances.2018018465
Published: 2018
Includes: Supplemental data
Journal Articles

Role of the hepcidin-ferroportin axis in pathogen-mediated intracellular iron sequestration in human phagocytic cells

Rodrigo Abreu, Frederick Quinn, Pramod K. Giri
Journal: Blood Advances
Blood Adv (2018) 2 (10): 1089–1100.
https://doi.org/10.1182/bloodadvances.2017015255
Published: 2018
Includes: Supplemental data
Journal Articles

Increased iron export by ferroportin induces restriction of HIV-1 infection in sickle cell disease

Namita Kumari, Tatiana Ammosova, Sharmin Diaz, Xionghao Lin, Xiaomei Niu, Andrey Ivanov, Marina Jerebtsova, Subhash Dhawan, Patricia Oneal, Sergei Nekhai
Journal: Blood Advances
Blood Adv (2016) 1 (3): 170–183.
https://doi.org/10.1182/bloodadvances.2016000745
Published: 2016
Includes: Supplemental data